Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 15385103

Long-term survival advantage for women treated with pegylated liposomal doxorubicin compared with topotecan in a phase 3 randomized study of recurrent and refractory epithelial ovarian cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Gynecol Oncol
Publication date
2004 Oct
First author
Gordon AN

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Gordon AN
      type
      Author
    2. name
      Tonda M
      type
      Author
    3. name
      Sun S
      type
      Author
    4. name
      Rackoff W
      type
      Author
    5. name
      Doxil Study 30-49 Investigators
      type
      CollectiveName
    Complete bibliographic record and source provenance
    authors
    1. name
      Gordon AN
      type
      Author
    2. name
      Tonda M
      type
      Author
    3. name
      Sun S
      type
      Author
    4. name
      Rackoff W
      type
      Author
    5. name
      Doxil Study 30-49 Investigators
      type
      CollectiveName
    bibliography ids
    1. nci-bib-bfa0c33686f389717e79953a
    book metadata
    content sha256
    daef63106e024e2f32b193e4a3d1adbe4dd2ccb10a20f3922fa47ad92848e318
    document type
    citation
    dois
    1. 10.1016/j.ygyno.2004.07.011
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:15385103
    immutable id
    pubmed:15385103@daef63106e024e2f32b193e4a3d1adbe4dd2ccb10a20f3922fa47ad92848e318
    journal
    abbreviation
    Gynecol Oncol
    issn electronic
    Source null
    issn print
    0090-8258
    issue
    1
    name
    Gynecologic oncology
    nlm unique id
    0365304
    pages
    1-8
    volume
    95
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      15385103
      provenance
      batch id
      97b9e848a139d5f8d462
      provider
      NCBI PubMed ESummary
      record sha256
      9f5613508dc1a320a56706e2dc6392f049e3adfe6ff87e3a347c4ca8106df212
      response sha256
      a316b1e9f1b120fc4a41adaaf2b205cc00afcf76d9a093a7cfa9ed2743d05be8
      retrieved at
      2026-09-09T23:45:57.930512+00:00
      publication date
      display
      2004 Oct
      precision
      month
      year
      2004
      publication types
      1. Clinical Trial
      2. Clinical Trial, Phase III
      3. Comparative Study
      4. Journal Article
      5. Multicenter Study
      6. Randomized Controlled Trial
      7. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/15385103/
      title
      Long-term survival advantage for women treated with pegylated liposomal doxorubicin compared with topotecan in a phase 3 randomized study of recurrent and refractory epithelial ovarian cancer.

      Preserved source evidence · Not medical advice